Literature DB >> 12595444

Human immune response to outer membrane protein CD of Moraxella catarrhalis in adults with chronic obstructive pulmonary disease.

Timothy F Murphy1, Charmaine Kirkham, Dai-Fang Liu, Sanjay Sethi.   

Abstract

Moraxella catarrhalis is a common cause of lower respiratory tract infection in adults with chronic obstructive pulmonary disease (COPD). The antibody response to outer membrane protein (OMP) CD, a highly conserved surface protein of M. catarrhalis under consideration as a vaccine antigen, was studied in adults with COPD following 40 episodes of infection or colonization. Following infection or colonization, 9 of 40 patients developed new serum immunoglobulin G (IgG) to OMP CD, as measured by enzyme-linked immunosorbent assay. Adsorption assays revealed that a proportion of the serum IgG was directed toward surface-exposed epitopes on OMP CD in six of the nine patients who developed new IgG to OMP CD. Immunoblot assays with fusion peptide constructs indicated that the new antibodies that developed after infection or colonization recognized conformational epitopes, particularly in the carboxy region of the protein. Three of 28 patients developed new mucosal IgA to OMP CD in sputum supernatants. This study establishes that OMP CD is a target of a systemic and mucosal immune response following infection and colonization in some patients with COPD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595444      PMCID: PMC148877          DOI: 10.1128/IAI.71.3.1288-1294.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

Review 1.  Moraxella (Branhamella) catarrhalis: clinical, microbiological and immunological features in lower respiratory tract infections.

Authors:  J J Christensen
Journal:  APMIS Suppl       Date:  1999

2.  Antibody response to outer membrane proteins of Moraxella catarrhalis in children with otitis media.

Authors:  K Mathers; M Leinonen; D Goldblatt
Journal:  Pediatr Infect Dis J       Date:  1999-11       Impact factor: 2.129

3.  Branhamella catarrhalis pneumonia.

Authors:  M West; S L Berk; J K Smith
Journal:  South Med J       Date:  1982-08       Impact factor: 0.954

4.  Airway inflammation and etiology of acute exacerbations of chronic bronchitis.

Authors:  S Sethi; K Muscarella; N Evans; K L Klingman; B J Grant; T F Murphy
Journal:  Chest       Date:  2000-12       Impact factor: 9.410

5.  Systemic and mucosal antibody response to Moraxella catarrhalis after exacerbations of chronic obstructive pulmonary disease.

Authors:  Faris Bakri; Aimee L Brauer; Sanjay Sethi; Timothy F Murphy
Journal:  J Infect Dis       Date:  2002-02-05       Impact factor: 5.226

6.  Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture.

Authors:  G Ninane; J Joly; M Kraytman
Journal:  Br Med J       Date:  1978-02-04

7.  Bactericidal antibody and susceptibility to otitis media caused by nontypable strains of Haemophilus influenzae.

Authors:  P A Shurin; S I Pelton; I B Tager; D L Kasper
Journal:  J Pediatr       Date:  1980-09       Impact factor: 4.406

8.  Development of bactericidal antibody during Branhamella catarrhalis infection.

Authors:  A J Chapman; D M Musher; S Jonsson; J E Clarridge; R J Wallace
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

9.  New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.

Authors:  Sanjay Sethi; Nancy Evans; Brydon J B Grant; Timothy F Murphy
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

10.  Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease.

Authors:  B Nicotra; M Rivera; J I Luman; R J Wallace
Journal:  Arch Intern Med       Date:  1986-05
View more
  18 in total

1.  Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease.

Authors:  Timothy F Murphy; Aimee L Brauer; Christoph Aebi; Sanjay Sethi
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 2.  Potential impact of a Moraxella catarrhalis vaccine in COPD.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Vaccine       Date:  2017-02-06       Impact factor: 3.641

3.  Serum antibody response to Moraxella catarrhalis proteins in stringently defined otitis prone children.

Authors:  Dabin Ren; Anthony L Almudevar; Timothy F Murphy; Eric R Lafontaine; Anthony A Campagnari; Nicole Luke-Marshall; Michael E Pichichero
Journal:  Vaccine       Date:  2017-07-26       Impact factor: 3.641

4.  Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children.

Authors:  Dabin Ren; Anthony L Almudevar; Timothy F Murphy; Eric R Lafontaine; Anthony A Campagnari; Nicole Luke-Marshall; Janet R Casey; Michael E Pichichero
Journal:  Vaccine       Date:  2015-09-21       Impact factor: 3.641

5.  Moraxella catarrhalis strain O35E expresses two filamentous hemagglutinin-like proteins that mediate adherence to human epithelial cells.

Authors:  Rachel Balder; Jonathan Hassel; Serena Lipski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

6.  Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis.

Authors:  Diana G Adlowitz; Sanjay Sethi; Paul Cullen; Ben Adler; Timothy F Murphy
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease.

Authors:  Timothy F Murphy; Aimee L Brauer; Christoph Aebi; Sanjay Sethi
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

8.  Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model.

Authors:  Dai-Fang Liu; John C McMichael; Steven M Baker
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

Review 9.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

10.  Identification of domains of the Hag/MID surface protein recognized by systemic and mucosal antibodies in adults with chronic obstructive pulmonary disease following clearance of Moraxella catarrhalis.

Authors:  Eric R LaFontaine; Lauren E Snipes; Brian Bullard; Aimee L Brauer; Sanjay Sethi; Timothy F Murphy
Journal:  Clin Vaccine Immunol       Date:  2009-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.